Brain Cancer

University of Maryland Medical Center

The University of Maryland Medical Center Brain Tumor Treatment and Research Center at the Greenebaum Comprehensive Cancer Center provides patients with efficient, comprehensive and innovative care through a compassionate, coordinated team of brain tumor specialists.

The center provides rapid access to state-of-the art therapies and groundbreaking clinical trials for both malignant and benign brain tumors in a patient-friendly environment.

To make an appointment with a brain tumor specialist, call 410-328-6148.

What Sets Us Apart

  • Team-oriented approach to care – Our highly-skilled, multidisciplinary team includes neurosurgeons, neuro-oncologists, medical oncologists, radiation oncologists, neuroradiologists, neuropathologists, physical medicine and rehabilitation specialists and nurse coordinators. These specialists embrace a team approach to care, working closely together to ensure patients received advanced, personalized and comprehensive treatments.
  • Highly experienced team – University of Maryland Medical Center brain tumor specialists are exceptionally trained and experienced doctors, nurses and therapists, ready to provide the most effective, safe care available. 
  • Access to the latest treatments and clinical trials – The brain tumor team strives to apply the most pertinent, updated information related to brain tumor biology to aid in decisions related to the timing and types of treatment. This includes offering a full-spectrum of innovative, exciting new treatment options through clinical trials when appropriate for each patient. Learn about a new clinical trial for glioblastoma which uses MRI-guided focused ultrasound.

Conditions We Treat

Primary brain tumors

  • Glioma & Glioblastoma  – The most common type of primary brain tumor, gliomas develop from glial cells. Glial cells account for nearly 90 percent of the cells in the brain and are involved in complex, important brain support functions. Glioblastoma tumors are one of the most aggressive kinds of glioma and are highly malignant.
  • Meningioma – Often benign, these tumors start in the meninges – thin tissues covering the brain and spinal cord.
  • Metastatic Brain Tumor - These tumors grow in the brain but originate from other parts of the body outside of the central nervous system.
  • Pituitary Adenoma - These noncancerous tumors form in the pituitary gland and grow slowly.
  • Primary Central Nervous System Lymphoma – This type of cancer starts in the brain or spinal cord lymphocytes, which are supposed to help the body fight disease and infection.
  • Pineal Tumors – Pineal tumors start from normal cells in the pineal gland, an endocrine gland located in the center of the brain that secretes hormones like melatonin. Tumors can cause problems with brain tissue, cerebrospinal fluid or hormone production.
  • Vestibular Schwannoma (Acoustic Neuroma) - These noncancerous tumors grow slowly can affect your hearing and balance.

Advanced Treatment Options

University of Maryland Medical Center Brain Tumor ProgramThe University of Maryland Medical Center Brain Tumor Treatment and Research Center uses modern technology to maximize patient safety and outcomes, including:

  • State-of-the-art, intraoperative imaging, which improves a surgeon’s precision and accuracy
  • The Edge, a minimally invasive radiosurgery device that allows precise, quick delivery of treatment
  • Gamma Knife, an alternative to traditional brain surgery
  • High-power microscopes
  • A Neurocritical Care Unit, which has advanced monitoring equipment, for post-operative care

Our neurosurgeons are also experts in “awake brain surgery,” also known as intraoperative brain mapping. The technique, used during many brain tumor procedures, enables surgeons to remove tumors that are otherwise inoperable. Patients are sedated at the beginning and end of the procedure but awake in the middle to test neurologic function. 

For patients with complex brain tumors, our team also partners with the Maryland Proton Treatment Center, which offers a highly advanced and precise form of radiation therapy that can increase radiation dose to a tumor while decreasing the dose to healthy, surrounding tissue.